Medication info
Anashi Tablet 200 mg (Acyclovir)

Anashi Tablet 200 mg (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
IYun Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
200 tablets/bottle, 100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 200704910 · Notified 2007.04.26 · Insurance code 658600560

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes); treatment of herpes zoster and chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to begin administration as soon as possible after infection; in recurrent cases, administration should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is preferable to begin administration as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more prone to neuropsychiatric adverse reactions, use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset whenever possible.

Ingredients

Manufacturer
IYun Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes); treatment of herpes zoster and chickenpox in children

  • Genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucous membrane, including primary and recurrent genital herpes. It is particularly effective for the treatment of herpes zoster virus infections, especially for alleviating acute pain. However, its efficacy for post-herpetic neuralgia has not yet been confirmed. It is also used for the treatment of chickenpox in children over 2 years of age. This medication effectively alleviates symptoms and aids in the treatment of various viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to begin administration as soon as possible after infection; in recurrent cases, administration should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is preferable to begin administration as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more prone to neuropsychiatric adverse reactions, use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset whenever possible.

Precautions

This medication should not be used in patients who have had an allergic reaction to this medication or its components. Patients with impaired renal function may experience neurological symptoms when using this medication, so caution is advised. Patients with decreased liver function should use this medication carefully, as it can worsen liver function. Young infants and children should be particularly cautious when using this medication, and it should be used only when necessary and in minimal doses. Elderly patients may have reduced kidney function; therefore, dosage and dosing intervals should be adjusted accordingly, and adequate fluid intake is necessary. During the use of this medication, there may be rare occurrences of severe allergic reactions such as anaphylactic shock, so if symptoms such as low blood pressure, difficulty breathing, or chest pressure occur, administration should be stopped immediately and appropriate treatment sought. Skin rash, fever, blisters, and urticaria may occur, so if these symptoms arise, stop taking the medication and consult a physician. Rarely, serious skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, so the condition of the skin should be carefully monitored. Psychological confusions, drowsiness, hallucinations, seizures, anxiety, and insomnia may occur, especially in elderly patients or those with decreased renal function. Renal impairment may lead to renal failure, hematuria, and proteinuria, so kidney function should be checked regularly. Blood-related issues such as leukopenia, anemia, bleeding, and purpura may occur, requiring periodic blood tests to monitor. Elevations in liver function test results or symptoms of hepatitis and jaundice may occur, necessitating ongoing monitoring of liver health. Gastrointestinal symptoms such as gastritis, nausea, vomiting, abdominal pain, or diarrhea may occur, and if severe, medication should be discontinued. General symptoms such as fever, muscle weakness, headache, and fatigue may occur, so general health should be closely monitored. Musculoskeletal pain or joint pain may occur. Cardiac abnormalities such as irregular heartbeat, blood pressure changes, and chest pain may occur, requiring attention to heart health. Difficulty urinating or urinary obstruction may infrequently occur, so urinary symptoms should also be carefully observed. This medication may interact with other drugs, so especially when used with medications that affect renal function or certain specific medications, consultation with a physician or pharmacist is recommended. Pregnant women or women who may become pregnant should consult a physician before using this medication, as it may pose risks to the fetus. During breastfeeding, this medication may be passed into breast milk, so it is advisable to stop breastfeeding while using it. In case of overdose, severe symptoms such as coma, seizures, or mental confusion may occur, requiring immediate medical attention. Adequate hydration during the use of this medication is essential to prevent dehydration and reduce the risk of kidney toxicity. Caution is advised during driving or operating hazardous machinery while taking this medication, as consciousness disturbances may occur.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 121 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impairment of concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • hepatic impairment
  • jaundice
  • elevated AST
  • elevated ALT
  • elevated LDH
  • elevated ALP
  • elevated total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizure
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature for optimal preservation of its efficacy.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

200 tablets/bottle, 100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.